A61K 40/414
Nervous system antigens
Official title: {Nervous system antigens}
A61K40/414 (Nervous system antigens) appears on 77 US grants and 167 published applications in this corpus.
Search patents in A61K- Granted patents
- 77
- Published applications
- 167
- Assignees
- 103
- Inventors
- 340
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 6 |
| 2003 | 0 | 4 |
| 2004 | 2 | 4 |
| 2005 | 1 | 6 |
| 2006 | 2 | 5 |
| 2007 | 0 | 2 |
| 2008 | 2 | 5 |
| 2009 | 1 | 7 |
| 2010 | 6 | 7 |
| 2011 | 1 | 0 |
| 2012 | 0 | 5 |
| 2013 | 4 | 4 |
| 2014 | 4 | 9 |
| 2015 | 2 | 5 |
| 2016 | 5 | 6 |
| 2017 | 4 | 5 |
| 2018 | 9 | 6 |
| 2019 | 1 | 6 |
| 2020 | 5 | 10 |
| 2021 | 1 | 12 |
| 2022 | 1 | 13 |
| 2023 | 4 | 13 |
| 2024 | 6 | 10 |
| 2025 | 6 | 9 |
| 2026 | 5 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treatment of headache disorders and neuropathic pain11 Aug 2026US 12,702,697 B2Washington University
- Compositions and methods for microglia replacement therapy28 Apr 2026US 12,612,599 B2Savanna Biotherapeutics, Inc.
- Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders21 Apr 2026US 12,605,409 B1University of South Florida
- Materials and methods for the treatment of Lewy body disorders24 Mar 2026US 12,583,894 B2University of Florida Research Foundation, Inc.
- Anti-dinitrophenol chimeric antigen receptors10 Mar 2026US 12,570,716 B2Seattle Children's Hospital
- Cd33 antibody compositions for treating alzheimer’s disease18 Jun 2026US 2026/0166145 A1
- Cell therapy for alzheimer's disease11 Jun 2026US 2026/0158142 A1Board of Regents of the University of Nebraska
- Car-t cell with good blood-brain barrier permeability, product, and use thereof7 May 2026US 2026/0124302 A1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Chimeric antigen receptors for treatment of neurodegenerative diseases and disorders7 May 2026US 2026/0125456 A1
- Chimeric antigen receptors for removal of amyloid12 Mar 2026US 2026/0070962 A1University of Tennessee Research Foundation
Most cited
By later US patents
- Multiponent adult stem cells and methods for isolation161US 7,015,037 B1M.C.L. Co., Ltd. · 2006
- Multipotent adult stem cells89US 7,659,118 B2ABT Holding Company · 2010
- Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy57US 6,844,314 B2Yeda Research and Development Co. Ltd. · 2005
- Methods of treating autoimmune disease via CTLA-4Ig39US 6,685,941 B1The Regents of the University of Michigan · 2004
- Use of modified cells for the treatment of multiple sclerosis23US 9,260,692 B2UniversitäT ZüRich · 2016